Analysis
Holtec Nuclear Corp set terms for its Nasdaq IPO this week, planning to sell 50 million shares at $15 to $18 each to raise as much as $900 million, multiple outlets reported, an implied market value of roughly $10.2 billion at the top of the range. Pulse covered Holtec's initial S-1 filing in July and its August amendment tying the offering to SMR demand; this week's move is the concrete pricing step that turns those filings into an actual, dated offering.
What Holtec sells
Holtec, based in Camden, New Jersey, is a vertically integrated nuclear technology company with three real businesses: spent nuclear fuel storage and transport, where it holds a market-leading position; nuclear plant decommissioning; and a small modular reactor program still in development. It also owns and is restarting the 800-megawatt Palisades plant in Michigan under long-term power purchase agreements -- the first US commercial reactor restart of its kind, and the piece of the business most directly tied to the current AI-driven demand for firm, always-on power.
“## Why nuclear is suddenly an IPO category Holtec is not the only energy name on this year's registration calendar chasing AI-driven power demand.”
Why nuclear is suddenly an IPO category
Holtec is not the only energy name on this year's registration calendar chasing AI-driven power demand. SB Energy, the solar and storage developer, filed an amended S-1 carrying a $439 billion contract backlog against $269 million of revenue tied to hyperscaler power-purchase agreements. The through-line across both is that data-center operators are now signing multi-decade power contracts to secure capacity, and that demand is pulling previously niche energy infrastructure companies toward public markets years earlier than they might otherwise have listed. Holtec's SMR program in particular is a direct bet that hyperscalers will contract for dedicated nuclear capacity the way they have already contracted for gas and solar.
What changed since August
The August S-1/A established the SMR-demand narrative and disclosed Holtec's basic financials; it did not set a share count or price range, which meant the market had no way to value the offering concretely. This week's filing is the first version investors can actually underwrite -- a specific valuation, a specific float, and a specific use-of-proceeds statement, which typically funds the Palisades restart and SMR development costs. A $10.2 billion valuation prices Holtec well below SB Energy's public backlog figures but with a business mix -- storage, decommissioning, restart, SMRs -- that carries less single-customer concentration risk than SB Energy's hyperscaler-dependent contracts.
The nuclear thesis carries real execution risk the price range does not resolve: SMR programs across the industry have a long history of missed timelines, and Palisades is the first restart of a shuttered US commercial reactor, a regulatory and engineering path with no direct precedent to benchmark against. Investors underwriting this IPO are pricing a story about 2030s power demand against a company whose near-term revenue still runs through slower-growing storage and decommissioning contracts.
